Medical Repatriation from Offshore Sites: Costs, Logistics and Decision Points

What is medical repatriation — and how is it different from a medevac?

Medical repatriation is the planned transfer of an ill or injured crew member back to their home country for continued care, once they have been stabilised and assessed as fit to travel. A medevac, by contrast, is the urgent evacuation of a patient to the nearest suitable medical facility, where speed is the priority (EMS Ambulance Service).

The two often occur in sequence. A technician injured on an offshore wind installation or a seafarer taken ill mid-passage may first be evacuated to the closest hospital — by SAR helicopter, crew transfer vessel or port diversion. Repatriation is the second, slower decision: once the immediate danger has passed, how does this person get home, at what cost, and who arranges it? Because repatriation is planned rather than reactive, it is also the stage where early clinical input and good logistics have the greatest influence on both cost and patient outcome.

For seafarers, repatriation is not merely an operational question but a legal entitlement. For offshore wind personnel, the obligations sit in employment contracts, insurance arrangements and the employer's duty of care — but the practical logistics chain is largely the same.

How much does medical repatriation cost?

Published price guides from repatriation providers span roughly £1,000 for a medical escort on a scheduled flight within Europe to more than £225,000 for an intercontinental air ambulance (SkyCare Repatriation, 2025). The mode of transport is the single biggest cost driver.

A stable patient who can sit or lie flat in a standard cabin travels with a medical escort on a commercial flight — the least expensive option. A patient who must remain supine but does not need intensive care can fly on a commercial airline stretcher, which requires a block of seats to be removed; airlines charge either a fixed rate or the equivalent of 6, 9, 12 or 18 seats at the highest economy fare for the installation (Jet Companion). Only patients needing continuous clinical care en route require a dedicated air ambulance.

SkyCare's published case examples illustrate the spread: a commercial medical escort from Spain to the UK for a stable patient cost under £4,000, while an ICU-level air ambulance from Florida to London exceeded £120,000 (SkyCare Repatriation, 2025). Distance, patient acuity, aircraft type, overflight permits and ground ambulance transfers at both ends all move the final figure.

Who pays for medical repatriation?

For seafarers, the shipowner pays. Regulation 2.5 of the Maritime Labour Convention 2006 entitles seafarers to repatriation at no cost to themselves in defined circumstances — including illness, injury or another medical condition that requires repatriation, once the seafarer is found medically fit to travel (MLC 2006, Regulation 2.5; UK MCA MGN 479). The shipowner's costs must cover passage, accommodation and food, luggage, and medical treatment until the seafarer is fit to travel, and ships must carry financial security to guarantee the obligation.

In practice, shipowners insure this exposure through their P&I club. Cover for crew illness and injury — including evacuation, hospitalisation, medical care and repatriation on medical grounds — is a core head of P&I cover, and crew claims are a major cost line: Gard alone registered roughly 3,000 crew claims in 2024, with illness the dominant category (Gard Crew Claims Report, 2025).

Offshore wind technicians employed shore-side typically fall outside MLC, and repatriation costs are met through the employer's insurance arrangements — business travel, personal accident or private medical cover — under the employer's duty of care. Crew on service operation vessels and other MLC-flagged tonnage in wind farm service may, however, hold seafarer status, so the answer for a given project depends on contract and flag: a point worth clarifying before an incident, not after.

How common is medical repatriation offshore?

More common than most HSE plans assume. A 2025 scoping review in International Maritime Health, covering 33 studies, over one million commercial seafarers and offshore workers and 28,170 medical repatriations, cites an estimate by Faurby and colleagues that roughly 1.7% of deployments end in repatriation (Belliveau & Journeay, 2025).

The same review found the leading causes were injuries and other external causes (25.2%), digestive system disease including dental problems (15.9%) and musculoskeletal disorders (13.3%) — with hand injuries, dental cases and back problems recurring across studies. Notably, these are dominated by conditions that develop or reveal themselves over days, not dramatic trauma. Insurer data points the same way: in Gard's claims portfolio, illness accounted for nearly 64% of crew claims, with abdominal pain, back pain and cardiac complaints topping the 2023 list (Gard Crew Claims Report, 2024).

What does the repatriation logistics chain actually involve?

A typical medical repatriation runs through five stages, each with its own decision point (UK P&I Club, 2024).

First, stabilisation and treatment at the receiving hospital after the initial evacuation. Second, the fit-to-travel assessment: the treating physician must confirm the patient can tolerate the journey, taking into account cabin pressure changes and the nature of the condition — and the airline's own medical clearance process must approve the booking. Third, mode selection: seated with escort, lie-flat, commercial stretcher or air ambulance, with oxygen or other support specified in advance. Fourth, the escorted journey itself, with a trained flight nurse or doctor accompanying the patient. Fifth, ground ambulance transfers at both ends and a clinical handover to the receiving facility at home.

The UK P&I Club notes that the process routinely involves the master, crewing department, agents, the P&I club and its local correspondent, hospitals, medical case-management companies and the family — a chain with that many hand-offs, where coordination gaps rather than clinical complications are often what drive delay and cost escalation. The club also notes that there is often an economic motivation to repatriate, particularly when treatment is being delivered in a high-cost jurisdiction such as the United States: care in the seafarer's home country may be significantly less costly, provided the same standard of care is available (UK P&I Club, 2024).

Where does telemedical assessment change the chain?

At three points: before evacuation, at the fit-to-fly decision, and in mode selection. In each case the role of a telemedical service is advisory — supporting the master, duty holder, treating physician and insurer, who retain the decision — but the effect on the chain can be substantial.

Before evacuation, a remote clinical assessment helps establish whether a case genuinely needs to leave the site at all. In the Turkish Telemedical Assistance Service dataset, 4,668 consultations from merchant cargo ships resulted in 471 medical evacuations — around one in ten contacts (Ocean & Coastal Management, 2021). Swedish TMAS data over 1997–2012 likewise showed seafarer evacuation rates falling over time as remote assessment matured (International Maritime Health, 2016). Every case managed in place is a repatriation chain that never starts.

At the fit-to-fly stage, clinicians who already know the case can help prepare the documentation the airline's medical department and the assistance company need, shortening the gap between hospital discharge readiness and an approved booking. And in mode selection, an accurate clinical picture is what separates a sub-£4,000 escorted commercial flight from a five-figure stretcher installation or a six-figure air ambulance: the published ranges above reward early, well-documented assessment. For offshore wind operators and DPAs alike, the practical takeaway is to connect clinical advice to the incident timeline early — the repatriation decisions that drive cost are made in the first days, not the last.

Sources

• EMS Ambulance Service — definition of medevac vs medical repatriation
• UK P&I Club (2024) — repatriating sick and injured seafarers: fit-to-travel, transport modes, coordination chain, US cost observation
• SkyCare Repatriation (2025) — cost guide: escort, air ambulance ranges, case examples
• Air Ambulance 1 — commercial stretcher cost range (US$15,000–$75,000+)
• Air Ambulance 1 — medical escort cost range (US$3,000–$25,000)
• Jet Companion — airline stretcher seat-block pricing (fixed rate or 6, 9, 12 or 18 seats at highest economy fare)
• MLC 2006, Regulation 2.5 — seafarer repatriation entitlement and shipowner obligations
• UK MCA MGN 479 — MLC repatriation guidance including medical grounds and fit-to-travel
• Belliveau & Journeay (2025), International Maritime Health — scoping review: 28,170 repatriations, cause breakdown; cites Faurby et al. ~1.7% of deployments
• Gard (2025) — Crew Claims Report: ~3,000 crew claims in 2024
• Gard Crew Claims Report 2024 via Safety4Sea — illness ~64% of crew claims; top 2023 conditions
• Ocean & Coastal Management (2021) — Turkish TMAS: 4,668 consultations, 471 evacuations
• Westlund et al. (2016), International Maritime Health — Swedish TMAS 1997–2012 evacuation trends